Why Is Piramal Pharma Stock Signaling A Fresh Breakout?

How Is Piramal Pharma Stock Positioned For Its Next Uptrend?

About Piramal Pharma

Piramal Pharma Limited is a part of the Piramal Group and operates in the pharmaceutical and healthcare sector. The company is engaged in complex generics, contract development and manufacturing services (CDMO), and the consumer healthcare space. With a global footprint, it serves clients in regulated markets like the US, Europe, and emerging geographies. Its product portfolio includes over-the-counter (OTC) brands and formulations across multiple therapeutic categories.

Technical Outlook

The stock of Piramal Pharma recently bounced from the support level at Rupee 182 earlier this month. Last week, it successfully closed above a crucial resistance at Rupee 195, which has shifted the short-term outlook to positive. Importantly, the stock price is trading above both the 21-day and 50-day moving averages, reinforcing its bullish setup.

Breakout Signal: Despite a flat phase in recent sessions, the breakout remains valid. A new leg of uptrend is expected to unfold soon, giving traders an opportunity to participate.

Trading Strategy

• Buy Zone: Accumulate at Rupee 198 and Rupee 195
• Initial Stop-Loss: Rupee 190
• Targets: Rupee 210, Rupee 215, and finally Rupee 220
• Trailing Strategy: Shift stop-loss to Rupee 200 when stock hits Rupee 210. Tighten further to Rupee 208 once price touches Rupee 215.

Investor Takeaway

The breakout above resistance and strong moving average support make Piramal Pharma an attractive short-term trading candidate. Investors can benefit from disciplined buying and strict stop-loss adherence. A sustained move toward Rupee 220 can improve near-term sentiment in the stock.

For traders looking to navigate this volatile phase can make use of tips whose link are given below: 👉 Nifty Tip | BankNifty Tip

📌 Stay updated with more market insights at Indian-Share-Tips.com, which is a SEBI Registered Advisory Services.

---

SEBI Disclaimer: The information provided in this post is for informational purposes only and should not be construed as investment advice. Readers must perform their own due diligence and consult a registered investment advisor before making any investment decisions. The views expressed are general in nature and may not suit individual investment objectives or financial situations.

Piramal Pharma, Pharma stocks, Technical analysis, Trading strategy, Investor takeaway